The new mini docuseries "In Jesus' Name" goes beyond sensational Hollywood myths to the real-life experience of the Catholic rite of exorcism

BIRMINGHAM, Ala., Oct. 28, 2026 /PRNewswire/ -- Long after Halloween's Hollywood horrors and fictional hauntings fade from our screens, Catholic exorcists and the survivors of demonic oppression face the real-world reality of evil and spiritual warfare.

The new three-part documentary series "In Jesus' Name," premiering Oct. 28-30 at 4 pm ET on EWTN+ and EWTN.com, goes beyond cinematic myths to deliver a truthful and deeply human look inside modern-day exorcisms. Watch the official trailer.

Produced by EWTN Studios and Cumberland Creative, the free series offers authentic first-person accounts of experienced exorcists and survivors of demonic oppression who tell their stories of how evil operates and enters human lives, and, most importantly, how it can be, and is, overcome in Jesus' name.

"The purpose of this documentary is not to glorify or overly dramatize the work of the devil," explains Father Dan Reehil, a pastor and diocesan exorcist in the Diocese of Nashville, national director of Radio Maria USA and host of Battle Ready with Fr. Dan Reehil, in the series' opening scenes. "It's meant to educate you on the reality of spiritual warfare, which affects all of us every day, whether you believe in it or not, so that you may be aware and equipped to arm yourself against the enemy of your soul with all the weapons that Christ our Lord has given his Church."

The authoritative explanations by Father Reehil, Father Vincent Lampert, a pastor, who previously served for nearly 20 years as the designated exorcist for the Archdiocese of Indianapolis, and Archbishop Jeffrey Grob, Archbishop of Milwaukee and theological expert on the history of the Catholic rite of exorcism, aim to illuminated for audiences the dangers of witchcraft, the occult and other flirtations with evil, often promoted as harmless in pop culture, and show how to avoid that spiritually dark road.

"With 'In Jesus' Name,' we wanted to demystify the rite of exorcism and invite audiences to see how the Church responds to the presence of evil in an authoritative but compassionate and deeply human way," said Peter Gagnon, President of EWTN Studios. "By giving viewers rare access to experienced exorcists, theologians and those who have confronted profound spiritual darkness firsthand, the series reveals not only the reality of spiritual warfare but the truth at its heart: the battle is real, but God's love is greater."

The ordained exorcists provide a rare look into their training, the meaning behind the rites they use, and the emotional toll of their work. Complementing their perspective, the series also includes the voices of men and women who have experienced deliverance from spiritual oppression as well as mental health experts.

At its core, "In Jesus' Name," isn't about hyping up the drama of demonic deliverance, rather it aims to illuminate the very real human struggle between good and evil and the Catholic Church's centuries-old response, particularly offering hope that darkness is not the end of the story.

"In Jesus' Name" episode 1 is available and free to stream beginning Oct. 28 at 4 pm ET, with new episodes released Oct. 29 and Oct. 30, at EWTN.com or on the EWTN+ app on SmartTVs.

About EWTN Studios

Founded in 2025, EWTN Studios is the global film and television studio division of Eternal Word Television Network and the world's largest producer of Catholic media. Building on EWTN's legacy of creating impactful faith-based programming, EWTN Studios develops and produces a full slate of original series, films, documentaries, and digital content for audiences worldwide. With a mission rooted in Catholic storytelling and a commitment to elevating emerging and established creative talent, EWTN Studios brings a modern, cutting-edge production approach to content that inspires, informs, and reflects the rapidly evolving media landscape.

About EWTN+

EWTN+ is an on-demand digital platform that allows you to watch, listen to, and pray with a vast library of EWTN content across multiple devices when you want and where you want. EWTN+ is currently available free on EWTN.com, RokuTV, AppleTV, AmazonFireTV, and GoogleTV.

About Cumberland Creative  

Cumberland Creative is an award-winning content creation agency based in Nashville. We partner with businesses across the United States and around the globe to raise the bar for visual brand stories and produce results-driven, high-quality creative content.

SOURCE EWTN Global Catholic Network

Share this article

The 2026 tennis season is into its final stretch, and this week brings a pair of ATP 500 events in Vienna and Basel. With the Paris Masters next on the calendar and the ATP Finals approaching, there’s still plenty to play for as players look to finish strong on the indoor hard courts.

Both tournaments should give us plenty to work with from a betting perspective, and I’ll be posting my tennis best bets daily throughout the week. My write-ups will focus exclusively on ATP matches, but I’ll also have women’s picks available on the picks page.

With that in mind, keep reading for my tennis best bets for Thursday, October 29, at the Erste Bank Open and Swiss Indoors Basel.

RELATED: Check out some of the tennis bets our VSiN experts have for Tuesday!

Valentin Vacherot vs. Rafael Jodar

This play doesn’t feel that different from the one I had on Tallon Griekspoor on Wednesday. Is Jodar a better player than Vacherot? Sure. Does that mean he’s going to wipe the floor with him? Absolutely not.

Over the last 52 weeks, Vacherot is No. 6 on the ATP Tour in TennisViz’s Serve Quality (8.79) on hard courts. He’s excellent at hitting his spots and running through his service games. That’s massive when looking at this specific match, as it’s even easier to pick up quick holds indoors.

Jodar also happens to have a bit of a shaky serve. I know he has an all-world skill set, but the consistency hasn’t been there with the ball on his racquet. With that in mind, I wouldn’t be stunned if Vacherot sees a good amount of opportunities to break.

Vacherot is also incredibly underrated as a baseliner. He has a fantastic backhand, and he competes his butt off. So, he really should be able to make Jodar work for this one.

Bet: Vacherot +1.5 Sets (-120 – 1.5 units) & Vacherot ML (+260 – 0.5 units)

Matteo Berrettini vs. Flavio Cobolli

There’s a lot that Cobolli does at a higher level than Berrettini, but playing indoors levels the playing field a bit. Cobolli’s inconsistency as a server could really make him pay in these conditions, as Berrettini likely won’t run into many problems when the ball is on his racquet. Berrettini has the ability to serve up a ton of aces, and we should also see him put plenty of points away with his plus-one forehand. And speaking of that forehand, that’ll be the biggest weapon on the court in this match.

Berrettini hasn’t posted great results recently, but he also hasn’t been broken much either. So, he’s in a decent position to keep himself around in this match, waiting out a lazy service game from Cobolli to strike.

Berrettini has also enjoyed playing in Vienna in the past, posting some decent results here. He should head to the court with confidence that he can beat his fellow countryman.

Bet: Berrettini ML (-110)

Added Plays

I usually have A LOT MORE on the Pro Picks page. Those plays count towards my record and have been a big part of my success this season. Make sure you check them out. I’ll probably add a few more over there, so refresh that page throughout the day if you’re looking for action.

WHEN SOMEONE YOU KNOW IS DIAGNOSED WITH BREAST CANCER, KNOWING HER RADIATION OPTIONS CAN MAKE A DIFFERENCE

SOMERSET, N.J., Oct. 28, 2026 /PRNewswire/ -- Most people know to encourage the women in their lives to stay current with breast cancer screening. But when a friend, partner, mother or colleague is diagnosed, a different question often follows: What treatment options should she ask about?

This Breast Cancer Awareness Month, ProCure Proton Therapy Center is encouraging women and the people who support them to learn about proton therapy. If radiation is recommended, proton therapy may offer an alternative to conventional radiation for some patients, with the potential to reduce radiation exposure to nearby healthy tissue, including the heart and lungs.

Research published earlier this year in Breast Cancer Research gives patients another reason to ask about their options. Researchers examined 8,189 breast cancer patients who received radiation after surgery, including 501 treated with proton therapy. Lung changes visible on imaging occurred in 5.8% of the proton group compared with 10.0% of the conventional radiation group. Skin reactions were also less frequent in the proton group, at 13.4% compared to 20.9% in those who received conventional radiation therapy.

"For someone facing a breast cancer diagnosis, it can be hard to know which questions to ask," said Brian Chon, M.D., Medical Director at ProCure. "We want women and their families to know that, if radiation is part of the treatment plan, they can ask how each approach may affect nearby healthy tissue and whether proton therapy is right for them."

That question mattered to ProCure patient Liz. "I chose proton therapy because of the reduced risk to my heart and the reduced side effects," she said.

Another ProCure patient, Cathy, describes a similar journey after her breast cancer diagnosis. Already concerned about side effects of conventional radiation therapy, she undertook her own painstaking research process that ultimately led her to proton therapy.

"I was already a reader," she said, "but I read and researched until my eyes bled. Something had to be better than traditional radiation and not destroy healthy tissue to get to the bad cells."

ProCure encourages women to speak with their healthcare providers about when to schedule their next breast cancer screening. If a diagnosis occurs, patients can ask their care team to explain all appropriate treatment options, including how a proposed radiation plan may affect the heart, lungs and other healthy tissue.

About ProCure Proton Therapy Center

ProCure Proton Therapy Center in Somerset, NJ, opened in March 2012 as the tri-state region's first proton therapy facility, treating a range of cancers including diseases of the prostate, breast, lung, brain, head and neck, and gastrointestinal system, as well as sarcomas and many pediatric cases. Using the most advanced radiation treatment available, ProCure has treated more than 8,000 patients overall, including 750+ pediatric patients coming from the U.S. and abroad, and enables many cancer patients to choose a non-surgical treatment personalized to their medical needs and lifestyles, often with fewer side effects and less downtimeâgiving them more freedom to enjoy what matters most in their lives. For more information, visit ProCure.com.

Media Contact:

Sarah Ferrington, Marketing Manager

Phone: 732-357-2609

Email: [email protected]

SOURCE ProCure Proton Therapy Center

Share this article

TORONTO, Oct. 28, 2026 /PRNewswire/ -- Leading global children's entertainment company Spin Master Corp. announced today that a fourth PAW Patrol feature film is in the works. Cal Brunker (PAW Patrol: The Movieâ¢, PAW Patrol: The Mighty Movieâ¢, PAW Patrol: The Dino Movieâ¢, and The Nut Job 2: Nutty by Nature) returns to direct the latest instalment, and serves as co-writer for the film alongside Bob Barlen.

PAW Patrol's first three theatrical films became family favourites, all earning above 93% on the Rotten Tomatoes Popcornmeter and grossing a combined half-billion dollars at the global box office. The fourth film from Spin Master Entertainment, Paramount Animation and Nickelodeon Movies, is set to be distributed by Paramount Pictures in 2029. It is a Spin Master Entertainment production.

"PAW Patrol is a global entertainment phenomenon, and we're investing in the franchise to give fans more of what they love," said Vishnu Athreya, EVP & President of Spin Master Entertainment. "Looking to the future, we want to further expand the PAW Patrol universe through movies, series, specials, short-form video, and connected play to bring joy to the next generation of kids wherever they are. There are endless storytelling possibilities - this is just the beginning."

"PAW Patrol has a special place in the hearts of families around the world, and we're thrilled to continue the pups' journey on the big screen," said Jennifer Dodge, President of Paramount Animation. "Together, with our partners at Spin Master, we're excited to bring audiences another adventure that's made for the theatrical experience."

"Watching the way audiences have connected with the PAW movies has been incredible," said Brunker. "We've written a new story that we think audiences are going to love, and we can't wait to share it with the world."

Since its 2013 debut, PAW Patrol has become a beloved franchise for preschoolers and families with the series ranking as the #1 preschool show on Nick Jr. PAW Patrol's global reach spans over 190 territories and 33 languages, and it has amassed more than 10 million YouTube subscribers. The franchise's success also drives an active retail business, with more than 1,000 licensees worldwide and over $18 billion in lifetime retail sales generated through Skydance Products & Publishing, in addition to sales generated by Spin Master.

About Spin Master

Spin Master Corp. (TSX:TOY) is a leading global children's entertainment company, creating exceptional play experiences across its three creative centres: Toys, Entertainment and Digital Games. With worldwide toy distribution, Spin Master is best known for award-winning brands including PAW Patrol®, Melissa & Doug®, Bakugan® and Rubik's® Cube, and is the global toy licensee for other iconic properties. Through its in-house entertainment studio, the company creates and produces captivating multiplatform content including powerhouse preschool franchise PAW Patrol, along with other original shows, short-form series and feature films. With an established presence in digital games anchored by Toca Boca® and Piknikâ¢, Spin Master engages close to 60 million active users monthly in open-ended, creative and safe play. With 29 offices spanning nearly 20 countries, Spin Master employs more than 2,500 team members globally.

SOURCE Spin Master Corp.

Share this article

West Fraser Announces Third Quarter 2026 Results and Indefinite Curtailments in its OSB and Lumber Portfolios

VANCOUVER, BC, Oct. 28, 2026 /PRNewswire/ -- West Fraser Timber Co. Ltd. ("West Fraser" or the "Company") (TSX andNYSE: WFG) reported today the third quarter results of 2026 ("Q3-26"). The Company today also announced that it will indefinitely curtail its Huguley oriented strand board (OSB) mill in Lanett, Alabama and lumber mill in Leola, Arkansas. All dollar amounts in this news release are expressed in U.S. dollars unless noted otherwise.

Third Quarter Highlights

- Sales of $1.363 billion and earnings of $(80) million, or $(1.03) per diluted share

- Adjusted EBITDA1 of $38 million, representing 3% of sales

- Lumber segment Adjusted EBITDA1 of $34 million, including a $12 million favourable duties adjustment

- North America Engineered Wood Products ("NA EWP") segment Adjusted EBITDA1 of $(4) million

- Europe Engineered Wood Products ("Europe EWP") segment Adjusted EBITDA1 of $4 million

- Issued $500M Term Loan due September 2029, refinancing existing $300M Term Loan due May 2028

- Final AR7 Combined Duty Rate of 20.02%, maintaining lowest duty deposit rate advantage

- Increased liquidity position to $1.2B at the end of the third quarter, repaid $55 million of operating loans

- Guiding to lower end of previously released shipments guidance for SPF, SYP, and NA OSB

Indefinite Curtailment of two mills

West Fraser announced today that it will indefinitely curtail its Huguley OSB mill in Lanett, Alabama and lumber mill in Leola, Arkansas. These curtailments are expected to take effect in the fourth quarter following orderly wind-downs.

These decisions are the result of continued weakness in demand for wood products used in new home construction and repair and renovation applications. These actions are expected to reduce West Fraser's OSB capacity by 500 million square feet (3/8-inch) and SYP capacity by 225 million board feet, both on an annual basis.

We expect to record an asset impairment loss between $200 million to $220 million in the fourth quarter of 2026 in connection with these indefinite curtailments.

Commentary

"Over the last quarter, housing affordability continued to be a key constraint for wood products demand, which remains soft," said Sean McLaren, West Fraser's President and CEO. "We were also impacted by higher energy-related input costs. Our teams responded by running mills to demand, reducing inventory and controlling costs.

With no near-term visibility on an improvement in demand, we took further steps today to align our supply with customer demand through the indefinite curtailments of our Huguley OSB mill in Lanett, Alabama and our lumber mill in Leola, Arkansas.

Decisions like this are never easy because of the impact they have on our employees, their families and the communities where we operate. This action reflects the challenging market conditions facing our business and is not a reflection of the dedication and performance of our employees at Huguley and Leola, who have remained focused on operating safely while working diligently to position these mills for success. We are grateful for their hard work and contributions, and we are committed to supporting them through this transition.

We now expect 2026 SPF, SYP and North American OSB shipments to be towards the lower end of our guidance ranges. We also strengthened our financial position by refinancing our term loan into a new $500 million facility maturing in September 2029, ending the quarter with an undrawn revolver and $1.2 billion of available liquidity."

Results Summary

Third quarter sales were $1.363 billion, compared to $1.434 billion in the second quarter of 2026. Third quarter earnings were $(80) million, or $(1.03) per diluted share, compared to earnings of $(61) million, or $(0.78) per diluted share in the second quarter of 2026. Third quarter Adjusted EBITDA was $38 million compared to $59 million in the second quarter of 2026.

Liquidity and Capital Allocation

Cash and short-term investments increased to $203 million at October 2, 2026 from $202 million at December 31, 2025. Our $1 billion credit facility was undrawn as of October 2, 2026.

Capital expenditures were $212 million through the first nine months of 2026.

We paid $75 million in dividends year-to-date in 2026, and in the third quarter declared a $0.32 per share dividend paid in the fourth quarter of 2026.

From January 1, 2026 to October 2, 2026, no shares have been repurchased under the 2026 NCIB.

Outlook

Markets

The most significant uses for our North American lumber, OSB and engineered wood panel products are residential construction, repair and remodelling and industrial applications. Over the medium to longer term, improvements in housing affordability supported by U.S. government policy changes, reductions in inflation and interest rates and the advanced age of the U.S. housing stock (with a median home age of approximately 45 years) are expected to support new home construction and repair and renovation activity that generates lumber, plywood and OSB demand. In addition, growing market penetration of mass timber in industrial and commercial applications is also expected to become a more significant source of demand growth for wood building products in North America.

The seasonally adjusted annualized rate of U.S. housing starts was 1.22 million units in September 2026, with permits issued for 1.40 million units, according to the U.S. Census Bureau. While there are near-term uncertainties for new home construction and repair and renovation spending, owing in large part to weak consumer confidence and the level of mortgage rates and housing affordability, U.S. unemployment remains relatively low. However, U.S. employment growth has shown signs of slowing, while the conflict in the Middle East and the potential inflationary effects of tariff and other government policies may continue to exert upward pressure on inflation and interest rates. Given these developments, demand for our wood building products will continue to be challenged and may decline over the near term should the broader economy and employment slow or the trend in interest and mortgage rates continue to negatively impact consumer sentiment and housing affordability.

We expect industry demand across Europe and the U.K. to remain broadly in line with current levels in the near term, as the market continues to deal with elevated interest rates, inflationary pressures brought on by the conflict in the Middle East and broader economic uncertainty. Over the longer term, we expect demand for our European products to increase as adoption of OSB and timber-frame construction expands and repair and renovation activity remains supported by an aging housing stock. We believe we are well positioned to navigate market conditions and capitalize on the long-term growth opportunities in our European markets.

Operations

Demand for lumber products in 2026 reflects ongoing housing affordability challenges. Given the current operating environment, our 2025 lumber mill closures and tighter management of inventory, we estimate our SPF and SYP shipments to be at the low end of the previously stated range of 2.4 to 2.7 billion board feet for 2026.

In our NA EWP segment, we expect continued soft demand for our OSB products for the remainder of 2026 due to similar issues as faced in the Lumber segment. In light of these factors, as well as the High Level, Alberta OSB mill curtailment we completed in Q2-26, we estimate 2026 North American OSB shipments to be at the low end of the previously stated range of 5.9 to 6.3 billion square feet (3/8-inch basis).

In our Europe EWP segment, we anticipate 2026 demand for our MDF, particleboard, and OSB panel products to remain stable or show modest improvement compared to 2025 levels, while continuing to monitor macroeconomic conditions in the region. As such, we are reiterating 2026 OSB shipments targeted in the range of 1.0 to 1.25 billion square feet (3/8-inch basis).

Global events have contributed to an increase in oilâbased input costs, including fuels, chemicals and waxes. In our NA EWP segment, resin and wax costs are influenced by a range of factors, and while the relationship is not direct, resin and wax costs generally move in a similar direction as crude oil prices. Resin and wax costs increased by approximately $3 million in Q3-26 compared to Q2-26 across all of our mills, reflecting the combined impact of these factors.

In addition, logging and transportation costs across our lumber operations have increased due to higher diesel costs and, particularly in the U.S. South, reduced transportation labour availability. The impact of diesel inflation on SPF and SYP lumber costs is currently equivalent to approximately $15 per mfbm since the beginning of the year. In our OSB operations, higher diesel costs have been partially offset by lower pulpwood prices. On outgoing freight, much of this increase has been passed on via customer surcharges. We are managing our logging operations to mitigate the diesel price impact. In certain areas, we have purposely reduced log procurement in response to higher costs. Ongoing geopolitical uncertainty in the Middle East and broader macroeconomic conditions may continue to affect the duration and magnitude of these impacts.

Based on our current outlook and assuming stable market demand conditions and no further extension of lead times for ongoing or planned projects, capital expenditures for 2026 are expected to remain within the $300 million to $350 million range.1

Refer to the discussion in our 2025 Annual MD&A under "Risks and Uncertainties - Trade Restrictions" under "Risks and Uncertainties" for a detailed discussion of the risks and uncertainties associated with the imposition of tariffs, which may impact our operational guidance and our profitability during 2026.

Tariffs

On September 29, 2025, the U.S.

Five leaders recognized among Florida's most influential, reflecting a depth and breadth of leadership spanning health care, research, business and civic life while expanding access to academic medicine, accelerating innovation and fueling economic growth across Florida.

TAMPA, Fla., Oct. 28, 2026 /PRNewswire/ -- John Couris, president and CEO of Florida Health Sciences Center | Tampa General Hospital (TGH), earned Florida Trend's 2026 "Florida 500" distinction for the sixth consecutive year. He is joined by three members of the Florida Health Sciences Center Board of Directors: Board Chair Blake Casper, CEO of Caspers Company; Vice Chair and Corporate Secretary Gregory Celestan, president of Celestar, LLC and chief business officer of B&A Celestar Holdings Corporation; and Immediate Past Board and Governance Chair Drew Graham, managing partner of Ballast Point Ventures.

Jennifer Crabtree, president of the Tampa Medical & Research District (TMRD) and senior vice president at Tampa General, was also named to this year's list. Together, the five honorees reflect leadership spanning academic health care, research, business, innovation and civic life.

The "Florida 500" recognizes influential executives across more than 60 business categories. Florida Trend's editors select honorees through months of independent research and interviews, with an emphasis on professional impact, community service, philanthropy and sector leadership. Advertising plays no role in the selection.

"Our board is proud to see John recognized for a sixth consecutive year," said Casper. "He has translated an ambitious vision into meaningful results for patients and communities across Florida. Just as important, this year's list reflects the strength of the leaders serving alongside him, from board members who help guide our mission and growth to Jennifer's work building the Tampa Medical & Research District. Together, that leadership is expanding access to academic medicine, accelerating innovation and creating new opportunity for our region and state."

Since becoming president and CEO in 2017, Couris has led Tampa General's evolution, in partnership with the USF Health Morsani College of Medicine, into a statewide academic health system that includes Tampa General Hospital and more than 30 affiliated organizations. His focus on quality, safety, innovation and growth has included collaborations with Mass General Brigham, Palantir Technologies, GE HealthCare, Shields Health Innovations and Lifepoint Health.

Couris has positioned Tampa General as a real-world learning environment for scalable health care solutions, including artificial intelligence, predictive analytics and connected care. He also launched TGH Ventures, a corporate venture fund focused on emerging health care technologies.

Couris has championed the creation of the Tampa Medical & Research District as a platform for regional collaboration and growth. The district is projected to generate more than $8.3 billion in annual economic impact and support nearly 58,000 Florida jobs.

Additionally, Couris engages with state and federal leaders on health care policy. In January 2026, he was appointed by the White House to the HHS Advisory Council on Alzheimer's Research, Care, and Services, and he continues to serve on the Florida Health Care Innovation Council.

"I'm honored to be recognized alongside leaders who are making Florida a stronger, healthier place to live and work," said Couris. "This recognition reflects the commitment of our team members, physicians, board members and partners. Together, we are expanding access to world-class care, advancing innovation and building a medical and research district that will create opportunity for generations to come."

Casper, Celestan and Graham bring leadership across business, investment, national security and civic affairs to the Florida Health Sciences Center Board of Directors. Their collective experience strengthens the board's oversight of Tampa General's mission, strategy, quality, growth and long-term sustainability as an academic health system.

As board chair, Casper helps guide the board's governance and strategic stewardship. Celestan, as vice chair and corporate secretary, supports board leadership and governance while contributing experience from the defense and intelligence sectors. Graham, the immediate past board and governance chair, brings an investment and growth perspective shaped by his leadership at Ballast Point Ventures. Together, they work closely with executive leadership to guide Tampa General's continued growth as an academic health system, including its expansion across Florida, investments in innovation and research, strategic partnerships and commitment to delivering world-class care.

Crabtree has served as the Tampa Medical & Research District's (TMRD) inaugural president since October 2025. Anchored by Tampa General Hospital, the University of South Florida and the University of Tampa, TMRD brings together health care, higher education, research, business and civic partners to advance medical discovery, accelerate commercialization, attract investment and talent, and drive economic growth. In her role, Crabtree is responsible for moving the district from vision to execution by establishing its operating structure, leading the TMRD Advisory Committee, aligning anchor institutions and community partners, and advancing business development and investment opportunities.

As senior vice president at Tampa General, Crabtree also leads corporate communications across the health system. Her and her team's work drives strategic communications and partnership initiatives across the enterprise to position Tampa General as an industry-leading research and academic-based health system and elevate the unique expertise of its senior leaders. Before assuming her current responsibilities, she served as chief of staff to the president and CEO, helping coordinate executive priorities and advance key initiatives across the organization.

"Jennifer has been a driving force behind the Tampa Medical & Research District's vision and the partnerships bringing it to life," said Couris. "She connects people, ideas and institutions in ways that create lasting impact. Her recognition is a proud moment for Tampa General and for the broader district partnership."

Under Couris' leadership, Tampa General has continued to earn national recognition for clinical quality, academic medicine and organizational performance.

Tampa General has been ranked the No. 1 hospital in Tampa Bay by U.S. News & World Report for 11 consecutive years and named one of Newsweek's World's Best Hospitals for eight years. In U.S. News & World Report's 2026-2027 Best Hospitals rankings, five Tampa General specialties were ranked among the nation's top 50 and two additional specialties ranked among the top 10% of U.S. hospital programs.

Florida Trend is a leading publication covering business, economic and political news in Florida. The complete list of 2026 "Florida 500" honorees is available at floridatrend500.com.

ABOUT TAMPA GENERAL HOSPITAL

Tampa General Hospital, Florida's premier academic health system, is a 1,530-bed not-for-profit network of hospital and outpatient services spanning Florida. As the only center for Level I trauma and a comprehensive burn care center serving 23 counties, Tampa General delivers world-class care. The system's hospitals include Tampa General Hospital, Tampa General Rehabilitation Hospital, Tampa General Behavioral Health Hospital, all in Tampa; Tampa General Brooksville, Tampa General Spring Hill and Tampa General Crystal River. Tampa General is the highest-ranked hospital in Tampa Bay in U.S. News & World Report's 2026-2027 Best Hospitals for 11 consecutive years, with five medical specialties ranking among the top 50, two additional medical specialties ranked among the top 100 best hospital programs and two specialties ranked in the top 10% in the United States. As the first hospital in Florida to open a clinical command center for real-time situational awareness, the academic health system has elevated its digital care coordination center to the next level by leveraging artificial intelligence (AI) and its analytics platform across inpatient and outpatient care to ensure patients receive leading-edge care as quickly and safely as possible. Tampa General's commitment to growing and developing its team members is recognized by four prestigious Forbes magazine rankings â in the 2026 America's Best Large Employers ranked as the Tampa Bay region's #1 employer in the healthcare category for the sixth year in a row, the 2026 America's Best Employers for Company Culture, in the top 100 for the 2026 America's Best Employers for New Grads and the 2026 America's Best Employers for Women.

Tampa General is the area's safety-net hospital, caring for anyone regardless of ability to pay; in fiscal year 2024, Tampa General provided a net community benefit of approximately $289.1 million in the form of healthcare for underinsured patients, community education and financial support to community health organizations in Tampa Bay. It is recognized as one of the leading adult solid organ transplant centers in the nation and is the primary teaching hospital for the USF Health Morsani College of Medicine. With five medical helicopters, Tampa General transports critically injured or ill patients from surrounding counties to receive the advanced care their conditions require. Tampa General has a nationally accredited comprehensive stroke center and its 32-bed Neuroscience Intensive Care Unit is the largest on the West Coast of Florida. It is home to the Muma Children's Hospital at TGH, the Jennifer Leigh Muma 82-bed neonatal intensive care unit and a nationally accredited rehabilitation center.

- REVENUE OF $132.1 MILLION, UP 6% SEQUENTIALLY AND DOWN 2% YEAR-OVER-YEAR

- OPERATING INCOME OF $12.1 MILLION; EX-ITEMS, $12.6 MILLION, UP 35% SEQUENTIALLY AND DOWN 24% YEAR-OVER-YEAR

- GAAP EARNINGS PER SHARE OF $0.12; EPS EX-ITEMS OF $0.16, UP 46% SEQUENTIALLY AND DOWN 27% YEAR-OVER-YEAR

- FREE CASH FLOW OF $1.7 MILLION

- COMPANY REPURCHASED 87,873 SHARES OF COMMON STOCK, FOR $1.1 MILLION AGGREGATE PURCHASE PRICE

- COMPANY ANNOUNCES Q4 2026 QUARTERLY DIVIDEND

HOUSTON, Oct. 28, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported third quarter 2026 revenue of $132,100,000. Core's operating income was $12,100,000, with earnings per diluted share ("EPS") of $0.12, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $12,600,000, yielding operating margins of 10% with sequential incremental margins of 43%, and EPS, ex-items, of $0.16. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

Core's CEO, Larry Bruno, stated, "Our third quarter results delivered sequential revenue growth across both of our operating segments. International revenue was up in Europe-Africa, Asia-Pacific, Latin America, and the Middle East. There was a gradual improvement in activity in the Middle East, particularly late in the quarter. Improving demand across these international regions drove Reservoir Description revenue higher during the quarter, just above the top end of our guidance range. Production Enhancement's revenue growth was led by strong U.S. product sales, which benefited from modestly improved U.S. land completion activity and increased adoption of our proprietary completion technologies. International product sales also strengthened sequentially.

Looking at the mid to long term, we see our key international regions positioned for growth, including long-cycle offshore exploration and appraisal projects. Face-to-face meetings with clients throughout Asia-Pacific during the third quarter reinforced our view that the region is entering a period of sustained activity growth, with projects advancing across both conventional and unconventional plays. Core Lab's established global network has the Company well-positioned to support these programs. Although geopolitical conflicts in the Middle East and Russia-Ukraine still affect portions of our business, we are encouraged by improving demand and project momentum across our global client base."

Reservoir Description

Reservoir Description operations are closely correlated with trends in international and offshore activity levels, with approximately 80% of revenue sourced from projects originating outside the United States. Revenue for Reservoir Description in the third quarter of 2026 was $84,300,000, up 7% sequentially and down 4% year-over-year. Operating income on a GAAP basis was $7,700,000. Operating income, ex-items, was $8,100,000, yielding operating margins of 10% and strong sequential incremental margins of 78%.

Sequential revenue growth was driven by increased international demand for the Company's laboratory services, led by project work in Europe-Africa, Asia-Pacific, Latin America and the Middle East. Demand for assay services in the Middle East showed modest improvement late in the quarter but remained below pre-conflict levels. Ongoing geopolitical instability and associated sanctions in the Middle East and Russia-Ukraine continued to weigh on demand for these services.

During the third quarter of 2026, following the successful completion of an initial reservoir characterization study, a leading national oil company in the Middle East awarded Core Lab an expanded analytical program to evaluate its unconventional reservoirs. The initial study combined Core's proprietary technologies and integrated laboratory workflows to determine reservoir quality and fluid saturations. The expanded program will utilize Core Lab's PRISM⢠workflow, together with the Company's proprietary High Frequency NMR, NANO-k⢠100 Nano Permeametry, and Shale Matrix Permeameter ("SMP-200â¢") technologies. By integrating these laboratory measurements with other petrophysical and geological data, Core Lab is characterizing rock properties and fluid saturations, while also differentiating movable and immovable hydrocarbons. These datasets will assist the operator in evaluating hydrocarbon production potential and support development planning.

Also during the third quarter of 2026, Omega Oil and Gas engaged Core's team to evaluate more than 360 feet of conventional core and sidewall cores from two appraisal wells in Queensland's Taroom Trough in the Bowen Basin. High-quality whole core recovered from multiple hydrocarbon-bearing stratigraphic horizons are undergoing a comprehensive reservoir characterization program at Core Lab's Advanced Technology Center in Perth, Australia. Upon arrival at the laboratory, the cores were scanned using the Company's proprietary, non-invasive Dual Energy Computed Tomography technology. This technology provides early lithologic and petrophysical data to support the operator's initial assessment of potential pay intervals ahead of traditional physical laboratory measurements. The ongoing analytical program will combine these datasets to characterize reservoir quality and calibrate well logs, supporting Omega's appraisal of the resource. Core Lab is pleased to be assisting Omega Oil and Gas and its technical experts in the evaluation of this emerging play.

Production Enhancement

Production Enhancement operations, which are focused on complex completions in unconventional and conventional oil and gas reservoirs in the U.S., as well as projects across the globe, posted third quarter 2026 revenue of $47,800,000, up 4% sequentially and 3% year-over-year. Operating income for the third quarter on a GAAP basis was $4,300,000. Operating income, ex-items, was $4,400,000, yielding operating margins of 9%.

Sequential revenue growth was led by product sales, which rose 14%, with increases in both U.S. land and international markets. In the U.S., sales benefited from increased demand for the Company's completion products and growing adoption of its proprietary completion technologies. International product sales grew across Europe, Asia-Pacific and the Middle East. These gains were partially offset by the timing of diagnostic service activity in the Gulf of America, as several large projects originally scheduled for the third quarter were delayed, impacting both revenue and operating margins.

During the third quarter of 2026, a North American oilfield service company engaged Core Lab to enhance the efficiency and precision of its perforating operations. Core supplied its proprietary AERO FLEXâ¢, AERO POINTâ¢, and AERO SET⢠technologies, together with field implementation support. The integrated AERO⢠platform enabled the client to configure perforating assemblies for varying well requirements, simplifying assembly and redress procedures, and precisely orienting perforating charges within the wellbore. These engineered capabilities reduce preparation time and improve placement accuracy while supporting more consistent execution across multiple completion programs. Following successful field deployment, the client is expanding adoption of the AERO⢠product family throughout its North American operations.

Also during the third quarter, a Brazilian independent oil and gas operator focused on revitalizing mature onshore fields engaged Core Lab to support a waterflood optimization project. To improve sweep efficiency, the operator implemented a polymer treatment followed by a conventional waterflood traced with Core's proprietary SpectraFlood⢠technology. Analysis of produced water samples collected across the field showed delayed tracer breakthrough, indicating the polymer treatment was effective in slowing flood-front movement as intended. Given these results, the operator is expanding its use of Core Lab's flood diagnostic technology throughout its portfolio of more than 50 conventional assets, enhancing revenue opportunities for the Company in South America.

Liquidity, Free Cash Flow, Share Repurchases, and Dividend

Core continues to focus on maximizing free cash flow ("FCF"), a non-GAAP financial measure defined as cash from operations less capital expenditures. For the third quarter of 2026, cash from operations was $5,000,000, and capital expenditures associated with operations were $3,300,000, yielding FCF of $1,700,000. Certain raw materials used in the manufacturing of perforating systems have increased the cost of carrying inventory. Additionally, activity for both operating segments increased as we exited the third quarter of 2026, resulting in a higher level of accounts receivable at the end of the quarter. These two factors resulted in an increase of working capital as of September 30, 2026.

As previously disclosed, a fire in February 2024 damaged a building at Core Lab's Advanced Technology Center in Aberdeen, Scotland, and the related losses are covered by the Company's property and casualty insurance. Insurance proceeds, along with capital expenditures to replace equipment and restore the building, are reported separately within investing activities in the cash flow statement and are excluded from the calculation of FCF. These capital expenditures were approximately $500,000 in the third quarter of 2026.

In the third quarter of 2026, Core Lab repurchased 87,873 shares at an aggregate purchase price of approximately $1,100,000.

As of September 30, 2026, Core's net debt (defined as long-term debt less cash and cash equivalents) was $93,400,000, a reduction of $200,000. Also during the third quarter of 2026, the Company's leverage ratio (calculated as total net debt divided by trailing twelve months adjusted EBITDA) was under 1.50.

Compensation decisions draw on more data than ever, and that data is scattered across surveys, spreadsheets, and tools. Pave has built the place where it all comes together: one platform, powered by real-time intelligence and open to every source compensation teams trust. Today's strategic alliance with Levels.fyi is the latest step in that effort.

SAN FRANCISCO, Oct. 28, 2026 /PRNewswire/ -- Pave, the Agentic Compensation Management platform, today announced a strategic alliance with Levels.fyi, a compensation data platform that shows what work pays by company, level, location, and skill.

The alliance builds on Pave's partnerships with The Croner Company, Korn Ferry, WTW, and others and reflects a continuing commitment: making it easier for customers to bring the critical data behind their pay decisions into one place. Pave will continue to expand the network of data partners available on the platform, so that compensation teams don't have to stitch together sources by hand or choose between the ones they trust.

Through this strategic alliance, Pave customers can now access Levels.fyi data inside Pave Agent as well as Pave's Market Pricing tool to compare pay for a role across sources, benchmark against real-time Market Data, and price jobs and build competitive pay ranges. Customers can analyze Levels.fyi data alongside their own compensation data and any other data sources they choose to use. Pave Agent can use Levels.fyi data as a reference input to deliver compensation intelligence, so teams can ask a question in plain language and see the answer across Levels.fyi, their other sources, and real-time intelligence from 9,000-plus companies in Pave's dataset.

Levels.fyi adds a distinct lens on the market. Its data is contributed directly by the people earning it and backed by proof documents such as offer letters, W-2s, and pay stubs. Alongside survey and real-time views, it shows compensation teams what talent is actually earning.

With Levels.fyi data in Pave, mutual clients can:

- Ask Pave Agent to compare pay for a role across Levels.fyi, WTW, Korn Ferry, Croner, and Pave's real-time Market Data, all within one platform

- See self-reported Levels.fyi data next to survey and real-time benchmarks to understand where the market views agree and where they diverge

- Analyze Levels.fyi data alongside their own compensation data to see where their pay stands

- Give every analyst on the comp team, not just the person who manages the survey license, direct access to Levels.fyi data in their daily workflow

"Compensation decisions are only as good as the data behind them, and no single source tells the whole story," said Matt Schulman, CEO of Pave. "Our goal is for Pave to be the central source for the data compensation teams use to make decisions, with real-time intelligence from 9,000-plus companies as the foundation and every source a client trusts available alongside it. Croner, Korn Ferry, WTW, and now Levels.fyi are steps in that effort, and we will keep adding more. Clients shouldn't have to choose between the data sources they trust. They should have them all in one place."

"Effective compensation benchmarking starts with a simple question, 'How do we compare with the companies we actually compete against?'" said Zuhayeer Musa, co-founder of Levels.fyi. "Our data gives customers a current, company-level view of the market, backed by real proof such as offer letters and pay stubs. Bringing that perspective into Pave means teams can build the peer groups that matter to them, focus on a single competitor, and combine Levels.fyi's rich intelligence with the rest of their stack. Pave has set the standard for connected compensation, and we're excited to keep helping our mutual customers make faster, more confident pay decisions."

Levels.fyi data is now available to mutual customers through Pave Agent and Pave's Market Pricing tool. Existing customers can contact their account teams for access and availability details.

About Pave

Pave is the Agentic Compensation Management platform, powered by real-time compensation intelligence from 9,000-plus companies and a growing network of data partners. Beyond Market Pricing, Pave's platform spans Market Data benchmarking, Compensation Planning, Total Rewards, Team View, Visual Offer Letters, and Pave Agent, giving compensation teams one connected system to price roles, plan cycles, and communicate pay across the business. To learn more, visit www.pave.com.

About Levels.fyi

Levels.fyi is a compensation data platform that shows what work pays by company, level, location, and skill, and offers a different perspective of the market. Its data is contributed directly by the people earning it, backed by proof documents like offer letters, W-2s, and pay stubs. Levels.fyi reports 1M+ compensation data points, 2,100+ companies with fresh data, and 8,500+ company job ladders mapped, and says more than 3M professionals use the platform every month. To learn more, visit www.levels.fyi.

SOURCE Pave

Share this article

Updated Effective Date: Huron Consulting Group Set to Join S&P SmallCap 600

NEW YORK, Oct. 28, 2026 /PRNewswire/ -- Huron Consulting Group Inc. (NASD: HURN) will replace Supernus Pharmaceuticals Inc. (NASD: SUPN) in the S&P SmallCap 600 before the opening of trading on Tuesday, November 3, instead of Monday, November 2. S&P SmallCap 600 constituent Indivior Pharmaceuticals Inc. (NASD: INDV) is acquiring Supernus Pharmaceuticals in a transaction expected to close soon, subject to final closing conditions. Post merger, Indivior Pharmaceuticals will assume the name Supernus Inc. and will trade under the symbol SUPN. It will remain in the S&P SmallCap 600.

S&P Dow Jones Indices announced the original November 2 effective date in its October 22, 2026 press release and is revising the effective date due to a special dividend ex- date announcement related to the merger.

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spglobal.com/spdji/en/.

FOR MORE INFORMATION:

S&P Dow Jones Indices

[email protected]

Media Inquiries

[email protected]

SOURCE S&P Dow Jones Indices

Share this article

In the news release, 7-Eleven, Inc. Gives Global Flavors Their Main Character Moment with New Flavors of Korea Menu, issued 28-Oct-2026 by 7-Eleven, Inc. over PR Newswire, we are advised by the company that a change has been made. The complete, corrected release follows, with additional details at the end:

7-Eleven, Inc. Gives Global Flavors Their Main Character Moment with New Flavors of Korea Menu

Sweet heat, savory bites and a mini-series drama are taking over the aisles of 7-Eleven, Inc. with the new Korean-inspired menu

IRVING, Texas, Oct. 28, 2026 /PRNewswire/ -- 7-Eleven, Inc., the world's largest convenience retailer, is bringing Korean-inspired flavors to stores with the launch of its new Flavors of Korea menu. Available at participating 7-Eleven®, Speedway®, and Stripes® stores, the new menu brings a taste of Korea to the convenience aisle with an exciting mix of new menu offerings and flavorful twists on fan favorites. From sweet and spicy flavors and delicious sauces to crave-worthy combinations across wings, pizza, sandwiches, dumplings and more, fans can explore Korean-inspired flavors in new dishes and familiar favorites.

Experience the full interactive Multichannel News Release here: https://www.multivu.com/7-eleven/9365953-en-7-eleven-new-flavors-of-korea-menu

The Flavors of Korea menu showcases how 7-Eleven continues to explore new flavors and global cuisines. The expansive lineup brings Korean-inspired ingredients and flavor profiles across hot foods and chilled, ready-to-eat meals, giving customers plenty of ways to discover global flavors close to home.

The new Flavors of Korea menu includes:

- bibigo Spicy Chicken Dumplings: Bite-sized dumplings that deliver a spicy, savory kick with a combination of chicken, green onion, glass noodles, cabbage and soy sauce. Packed with bold Korean-inspired flavor, customers can dig into a 10-piece bibigo Spicy Chicken Dumplings for $5.*

- bibigo Korean BBQ-Style Pizza: Pizza gets a sweet-and-savory twist with the new Korean BBQ-Style Pizza, topped with seasoned beef, caramelized onions, shoestring carrots, roasted garlic, green onions, a shredded blend of mozzarella and cheddar cheese and bibigo Korean BBQ sauce.*

- Gochujang Boneless Wings: Boneless chicken wings get a tangy twist, seasoned with a gochujang glaze and garlic, doenjang, ginger and chili paste. Flavor fans can grab an 8-piece Gochujang Boneless Wings for $5 for the perfect balance of sweet and savory.*

- K Town Chicken Salad Sando: Inspired by the classic convenience-store sandwich, the K Town Chicken Salad Sando brings a spicy touch to the chilled, ready-to-go favorite. The sandwich features chicken with the bold kick of gochujang, crispy celery, toasted sesame oil and parmesan cheese on a fire & milk marble bread.*

- Korean-Style BBQ Sauced Taquito: The 7-Eleven favorite gets a flavorful twist for a limited time with white meat chicken, onions, soy sauce, K BBQ style seasoning and sauce, all rolled in a battered tortilla.*

- K Noodle Salad: A refreshing mix of sweet, spicy and tangy goodness, the new K Noodle Salad features chilled sÅmen noodles layered with shredded carrots, napa cabbage, Kimchi, green onions, diced cucumbers, topped with sweet and spicy Gochujang dressing for a zesty finishing touch.

- Korean Style BBQ Seasoned Sausage: The roller grill is getting in on the action with the limited-time Korean Style BBQ Seasoned Sausage, made with fresh-cut, never-frozen pork blended with Korean BBQ flavor including brown sugar, onion, garlic, soy sauce and ginger.*

- The Seoul Style Sweet Heat Chicken Sandwich at Raise the Roost®: Sweet and spicy flavors take center stage with the new Seoul Sweet Heat Chicken Sandwich, featuring crispy chicken tenders tossed in sweet-heat Korean BBQ sauce, layered with smoky bacon, melty pepper jack cheese, crunchy coleslaw and Korean BBQ aioli on a buttery toasted brioche bun. Customers can also enjoy the $5 Crave Combo, featuring their choice of 8-piece nuggets in the new limited-time Korean BBQ flavor, 2-piece Tenders or two Crispy Wraps, paired with a small side and Big Gulp® drink. Both offerings are available at participating Raise the Roost restaurants. **

"At 7-Eleven, we believe that exploring global flavors should be easy and exciting," said Brandon Brown, Senior Vice President, Fresh Foods and Beverages at 7-Eleven, Inc. "With the Flavors of Korea menu, we're giving customers even more ways to explore Korean-inspired cuisine, whether they're trying something completely new or enjoying a fresh take on a longtime favorite. It's all about giving customers new ways to enjoy their go-to favorites while discovering flavors from around the world."

The flavor takeover doesn't stop at the menu. To celebrate the launch, 7-Eleven created a K-drama mini-series airing on the 7-Eleven and Speedway Instagram and TikTok channels. The seven-episode series follows two classmates and 7-Eleven regulars whose lives become intertwined during late-night snack runs. Beginning November 2, fans can catch new 60-second episodes every Monday and Thursday through November 23, with each episode serving up fresh drama and new cravings. And for fans looking to get a taste of the action, each episode will feature a limited-time discount on a spotlighted menu item.

"K-dramas run on heightened moments. And some of the most memorable ones happen over something as simple as a late-night meal at a convenience store," said director Danny Lee. "That's what made 7-Eleven's new Korean-inspired menu a natural fit. We built 7 vertical episodes around it and shot all of them in a real 7-Eleven with the food at every turning point. In this genre the style is core to the storytelling, so we leaned into those familiar devices with some American cinematic flair, from the characters and humor to the visual details and, of course, the food from 7-Eleven."

Turn up the flavor and sip on something refreshing! For a limited time, 7Rewards® and Speedy Rewards® members can add on any 20-ounce Coke or Pepsi beverage for only $1 with the purchase of two slices of pizza, bibigo Spicy Chicken Dumplings, Gochujang Boneless Wings or a deli sandwich at participating stores.***

Ready to explore? Fans can find the Flavors of Korea menu items at participating stores for a limited time and follow the K-drama-inspired series on 7-Eleven and Speedway Instagram and TikTok channels.

* Offer valid 10/28/26 - 1/5/27 at participating stores. Plus tax. ©2026 7-Eleven, Inc. All rights reserved.

** Offers valid 10/28/26 - 1/6/27 at participating Raise the Roost® locations. Plus tax. ©2026 7-Eleven, Inc. All rights reserved.

*** Offer valid 10/28/26 - 1/6/27 only for 7Rewards® and Speedy Rewards® members. Plus tax. ©2026 7-Eleven, Inc. All rights reserved.

About 7-Eleven, Inc.

7-Eleven, Inc. is the premier name in the U.S. convenience-retailing industry. Based in Irving, Texas, 7-Eleven operates, franchises and/or licenses more than 12,000 stores in the U.S. and Canada. In addition to 7-Eleven® stores, 7-Eleven, Inc. operates and franchises Speedway®, Stripes®, Laredo Taco Company® and Raise the Roost® Chicken and Biscuits locations. Known for its iconic brands such as Slurpee®, Big Bite® and Big Gulp®, 7-Eleven offers customers fresh, high-quality and convenient food options like sandwiches, salads, side dishes, cut fruit and protein boxes, as well as pizza, chicken wings and mini beef tacos. 7-Eleven also offers customers industry-leading packaged products at an outstanding value with its 7-Select⢠private brand. Customers can earn and redeem points on various items in stores nationwide through its 7Rewards® and Speedy Rewards® loyalty programs, which have more than 100 million members. Customers can also place an order in the 7NOW® delivery app with real-time tracking and delivery typically in about 30 minutes, depending on the market, driver availability, weather, traffic conditions, and other factors. Find out more online at www.7-eleven.com.

CONTACT: 7-Eleven, Inc.

Corporate Communications

[email protected]

Correction: An earlier version of this release incorrectly included '"Johnsonville" in bullet 7.

SOURCE 7-Eleven, Inc.

Share this article